TOK-001 10mg 10mg | Purity Not Available
Adooq Bioscience
TOK-001 (Galeterone) is both an androgen receptor antagonist and CYP17A1 inhibitor.
More Information Supplier PageTOK-001 (Galeterone) is both an androgen receptor antagonist and CYP17A1 inhibitor.
More Information Supplier PageCetaben is a unique, PPAR??-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
More Information Supplier PageCetaben is a unique, PPAR??-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
More Information Supplier PageCetaben is a unique, PPAR??-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
More Information Supplier PageCetaben is a unique, PPAR??-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
More Information Supplier PageINCB8761(PF-4136309) is a potent, selective, and orally bioavailable CCR2 antagonist.
More Information Supplier PageINCB8761(PF-4136309) is a potent, selective, and orally bioavailable CCR2 antagonist.
More Information Supplier PageINCB8761(PF-4136309) is a potent, selective, and orally bioavailable CCR2 antagonist.
More Information Supplier PageTOK-001 (Galeterone) is both an androgen receptor antagonist and CYP17A1 inhibitor.
More Information Supplier PageTOK-001 (Galeterone) is both an androgen receptor antagonist and CYP17A1 inhibitor.
More Information Supplier Page